PIMCO's Ivascyn says vaccine boosts outlook for some pandemic-hit junk bonds
Positive data on an experimental COVID-19 vaccine has improved the outlook for high-yield credit, especially for companies slammed by the coronavirus pandemic, said Dan Ivascyn, chief investment...